Zhimeng Biopharma

OverviewSuggest Edit

Zhimeng Biopharma (上海挚盟医药科技有限公司) is a biotech company developing medicines for the treatment of chronic hepatitis B (CHB) and severe neurological diseases. The company develops small molecule drugs to treat epilepsy, pains, and strokes.
TypePrivate
Founded2017
Websitecore-biopharma.com

Latest Updates

Employees (est.) (Feb 2020)12
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Zhimeng Biopharma Financials and Metrics

Summary Metrics

Founding Date

2017

Zhimeng Biopharma total Funding

$142 m

Zhimeng Biopharma latest funding size

$142 m

Time since last funding

3 years ago

Zhimeng Biopharma investors

Zhimeng Biopharma's latest funding round in November 2019 was reported to be $142 m. In total, Zhimeng Biopharma has raised $142 m
Show all financial metrics

Zhimeng Biopharma Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Zhimeng Biopharma Online and Social Media Presence

Embed Graph

Zhimeng Biopharma Frequently Asked Questions

  • When was Zhimeng Biopharma founded?

    Zhimeng Biopharma was founded in 2017.

  • How many employees does Zhimeng Biopharma have?

    Zhimeng Biopharma has 12 employees.

  • Who are Zhimeng Biopharma competitors?

    Competitors of Zhimeng Biopharma include Surface Ophthalmics, Andromaco and Apnimed.